These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18263597)

  • 21. Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function.
    Mouthon L; Carpentier PH; Lok C; Clerson P; Gressin V; Hachulla E; Bérezné A; Diot E; Van Kien AK; Jego P; Agard C; Duval-Modeste AB; Sparsa A; Puzenat E; Richard MA;
    Semin Arthritis Rheum; 2017 Jun; 46(6):759-766. PubMed ID: 28214014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.
    Rosato E; Molinaro I; Borghese F; Rossi C; Pisarri S; Salsano F
    J Rheumatol; 2010 Dec; 37(12):2531-9. PubMed ID: 20810512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval.
    Agard C; Carpentier PH; Mouthon L; Clerson P; Gressin V; Bérezné A; Diot E; Jego P; Lok C; Sparsa A; Chatelus E; Van Kien AK; Quéré I; Sibilia J; Hachulla E
    Scand J Rheumatol; 2014; 43(5):398-402. PubMed ID: 24720440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
    Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
    Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Bosentan in treatment of refractory sclerodermic bone prominences skin ulcers.
    Richetta AG; Mattozzi C; Maiani E; D'Epiro S; Cimillio M; Carboni V; Giancristoforo S; Calvieri S
    Clin Ter; 2008; 159(5):317-9. PubMed ID: 18998033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.
    Denton CP; Humbert M; Rubin L; Black CM
    Ann Rheum Dis; 2006 Oct; 65(10):1336-40. PubMed ID: 16793845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis.
    Dhillon S
    Drugs; 2009 Oct; 69(14):2005-24. PubMed ID: 19747014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers.
    Jain M; Varga J
    Expert Opin Pharmacother; 2006 Aug; 7(11):1487-501. PubMed ID: 16859432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of systemic-sclerosis-related digital ulcers with a selective endothelin type A receptor antagonist (sitaxentan).
    Gholam P; Sehr T; Enk A; Hartmann M
    Dermatology; 2009; 219(2):171-3. PubMed ID: 19590168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)].
    Riccardi MT; Chialà A; Lannone F; Grattagliano V; Covelli M; Lapadula G
    Reumatismo; 2007; 59(2):135-9. PubMed ID: 17603693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study.
    Cozzi F; Pigatto E; Rizzo M; Favaro M; Zanatta E; Cardarelli S; Riato L; Punzi L
    Clin Rheumatol; 2013 May; 32(5):679-83. PubMed ID: 23344686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease.
    Ahmadi-Simab K; Hellmich B; Gross WL
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():44-8. PubMed ID: 16919010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Connective tissue diseases: Treatment of digital ulcers in systemic sclerosis.
    Lambova S; Müller-Ladner U
    Nat Rev Rheumatol; 2011 Jan; 7(1):5-6. PubMed ID: 21119606
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of Bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: a prospective open-label study.
    Furuya Y; Kuwana M
    J Rheumatol; 2011 Oct; 38(10):2186-92. PubMed ID: 21885489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a sequential therapy of bosentan and iloprost versus a monotherapy with bosentan in the treatment of scleroderma related digital ulcers.
    Hafner F; Thomas G; Froehlich H; Steidl K; Brodmann M
    Int Angiol; 2011 Oct; 30(5):493-5. PubMed ID: 21804491
    [No Abstract]   [Full Text] [Related]  

  • 36. Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.
    McLaughlin VV
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():10-5. PubMed ID: 16919005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.
    Humbert M; Cabane J
    Rheumatology (Oxford); 2003 Jan; 42(1):191-3. PubMed ID: 12509640
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan.
    Selenko-Gebauer N; Duschek N; Minimair G; Stingl G; Karlhofer F
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii45-8. PubMed ID: 16987835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world effectiveness and safety of bosentan in Japanese patients with systemic sclerosis: A single-center retrospective study.
    Ishikawa M; Endo Y; Yamazaki S; Sekiguchi A; Uchiyama A; Motegi SI
    J Dermatol; 2023 Jun; 50(6):828-832. PubMed ID: 36651000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment with bosentan of non-digital skin ulcers in severe scleroderma.
    Ferreira ME; Scheinberg MA
    Ann Rheum Dis; 2008 Dec; 67(12):1784-5. PubMed ID: 19005155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.